442 related articles for article (PubMed ID: 12908965)
21. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ
Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847
[TBL] [Abstract][Full Text] [Related]
22. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
23. Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells.
Li M; Husic N; Lin Y; Christensen H; Malik I; McIver S; LaPash Daniels CM; Harris DA; Kotzbauer PT; Goldberg MP; Snider BJ
J Neurosci Methods; 2010 May; 189(1):56-64. PubMed ID: 20347873
[TBL] [Abstract][Full Text] [Related]
24. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
25. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
26. The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts.
Volkova NA; Fomina EG; Smolnikova VV; Zinovieva NA; Fomin IK
J Biol Chem; 2014 Jul; 289(29):20158-69. PubMed ID: 24878957
[TBL] [Abstract][Full Text] [Related]
27. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
Ikeda Y; Collins MK; Radcliffe PA; Mitrophanous KA; Takeuchi Y
Gene Ther; 2002 Jul; 9(14):932-8. PubMed ID: 12085241
[TBL] [Abstract][Full Text] [Related]
28. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.
Mitta B; Rimann M; Ehrengruber MU; Ehrbar M; Djonov V; Kelm J; Fussenegger M
Nucleic Acids Res; 2002 Nov; 30(21):e113. PubMed ID: 12409472
[TBL] [Abstract][Full Text] [Related]
29. Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis.
Douglas JL; Lin WY; Panis ML; Veres G
Hum Gene Ther; 2001 Mar; 12(4):401-13. PubMed ID: 11242532
[TBL] [Abstract][Full Text] [Related]
30. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors.
Barrette S; Douglas JL; Seidel NE; Bodine DM
Blood; 2000 Nov; 96(10):3385-91. PubMed ID: 11071632
[TBL] [Abstract][Full Text] [Related]
32. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral gene transfer into the dorsal root ganglion of adult rats.
Yu H; Fischer G; Jia G; Reiser J; Park F; Hogan QH
Mol Pain; 2011 Aug; 7():63. PubMed ID: 21861915
[TBL] [Abstract][Full Text] [Related]
34. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
35. Lentiviral and murine retroviral transduction of T cells for expression of human CD40 ligand.
Barry SC; Seppen J; Ramesh N; Foster JL; Seyama K; Ochs HD; Garcia JV; Osborne WR
Hum Gene Ther; 2000 Jan; 11(2):323-32. PubMed ID: 10680845
[TBL] [Abstract][Full Text] [Related]
36. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
[TBL] [Abstract][Full Text] [Related]
37. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
[TBL] [Abstract][Full Text] [Related]
38. An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner.
Hager S; Frame FM; Collins AT; Burns JE; Maitland NJ
Hum Gene Ther; 2008 Aug; 19(8):840-50. PubMed ID: 18627247
[TBL] [Abstract][Full Text] [Related]
39. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.
Guenechea G; Gan OI; Inamitsu T; Dorrell C; Pereira DS; Kelly M; Naldini L; Dick JE
Mol Ther; 2000 Jun; 1(6):566-73. PubMed ID: 10933981
[TBL] [Abstract][Full Text] [Related]
40. Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression.
Kimura T; Koya RC; Anselmi L; Sternini C; Wang HJ; Comin-Anduix B; Prins RM; Faure-Kumar E; Rozengurt N; Cui Y; Kasahara N; Stripecke R
Mol Ther; 2007 Jul; 15(7):1390-9. PubMed ID: 17505480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
